` PHAR (Pharming Group NV) vs MRUS (Merus NV) Comparison - Alpha Spread

PHAR
vs
MRUS

Over the past 12 months, PHAR has significantly outperformed MRUS, delivering a return of +30% compared to the MRUS's +1% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
PHAR
MRUS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

PHAR Intrinsic Value
HIDDEN
Show
MRUS Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Pharming Group NV
NASDAQ:PHAR
10.58 USD
Merus NV
NASDAQ:MRUS
53.82 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
PHAR vs MRUS

PHAR
MRUS
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Pharming Group NV
Revenue
Merus NV
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
PHAR vs MRUS

PHAR
MRUS
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Pharming Group NV
NASDAQ:PHAR
Merus NV
NASDAQ:MRUS
What is Free Cash Flow?

Gross Margin

PHAR
89%
MRUS
0%
LTM 3Y Avg 5Y Avg 10Y Avg
Pharming Group NV
Merus NV

Operating Margin

PHAR
2.6%
MRUS
-550%
LTM 3Y Avg 5Y Avg 10Y Avg
Pharming Group NV
Merus NV

Net Margin

PHAR
-4.4%
MRUS
-506.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Pharming Group NV
Merus NV

FCF Margin

PHAR
1.6%
MRUS
-438.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Pharming Group NV
Merus NV

ROE

PHAR
-6.7%
MRUS
-58.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Pharming Group NV
Merus NV

ROA

PHAR
-3.3%
MRUS
-45.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Pharming Group NV
Merus NV

ROIC

PHAR
16.6%
MRUS
-149.3%
LTM 3Y Avg 5Y Avg 10Y Avg
Pharming Group NV
Merus NV

ROCE

PHAR
3%
MRUS
-56.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Pharming Group NV
Merus NV

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
PHAR vs MRUS

Loading

Performance Gap
PHAR vs MRUS

Performance Gap Between PHAR and MRUS
HIDDEN
Show

Performance By Year
PHAR vs MRUS

Loading
PHAR
MRUS
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare PHAR to other stocks
Unlock Full Access to Alpha Spread
Create Free Account